Published in Oncol Rep on January 04, 2001
Skin metastases from lung cancer: a case report. BMC Res Notes (2015) 0.89
Intratumoral Heterogeneity of Subcutaneous Nodules in a Never-Smoker Woman of Lung Squamous Cell Carcinoma Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography: A Case Report. Medicine (Baltimore) (2015) 0.81
Scalp metastasis as the first sign of small-cell lung cancer: management and literature review. Int Surg (2014) 0.80
The pilot study assessing efficacy and versatility of novel therapy for neoplastic ulceration: clinical and microbiological aspects. Postepy Dermatol Alergol (2013) 0.79
Zosteriform cutaneous metastases from an occult primary malignancy of lung identified by whole-body FDG PETCT imaging. Indian J Nucl Med (2016) 0.75
A Case of Multifocal Skin Metastases from Lung Cancer Presenting with Vasculitic-type Cutaneous Nodule. Indian J Dermatol (2015) 0.75
Lung cancer with skin and breast metastasis: a case report and literature review. Case Rep Pulmonol (2015) 0.75
Cutaneous Metastasis as a First Presentation for Lung Adenocarcinoma. N Am J Med Sci (2016) 0.75
Radiotherapy for Oligometastatic Lung Cancer. Front Oncol (2017) 0.75
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer (2009) 3.73
Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest (2006) 3.17
Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. Rheumatology (Oxford) (2007) 1.89
A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet (1994) 1.78
Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol (2012) 1.78
Preconditioning effects of levosimendan in coronary artery bypass grafting--a pilot study. Br J Anaesth (2006) 1.64
Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol (2001) 1.63
Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan. Pharmacogenomics J (2010) 1.63
Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions. Radiol Med (2007) 1.58
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. Ann Oncol (2004) 1.51
Italian cross-sectional growth charts for height, weight and BMI (6-20 y). Eur J Clin Nutr (2002) 1.46
Insulin autoantibodies as markers of potential diabetes mellitus. Lancet (1989) 1.40
Comparison between intercostal and diaphragmatic flap in the surgical treatment of early bronchopleural fistula. Eur J Cardiothorac Surg (1997) 1.39
Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol (2004) 1.39
Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance? Ann Oncol (2012) 1.28
Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene. Diabetologia (2006) 1.26
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. Ann Oncol (2003) 1.20
Cetuximab and irinotecan as third-line therapy in advanced colorectal cancer patients: a single centre phase II trial. Br J Cancer (2006) 1.14
Prognostic value of immunohistochemical expression of p53, bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology (2004) 1.08
Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance. Ann Surg Oncol (2004) 1.07
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes. Clin Exp Immunol (2008) 1.07
Thoracoscopic thymectomy in autoimmune myasthesia: results of left-sided approach. Ann Thorac Surg (2000) 1.06
Adjuvant colon cancer chemotherapy: where we are and where we'll go. Cancer Treat Rev (2010) 1.05
No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes. Diabetologia (2011) 1.05
Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. Ann Thorac Surg (2000) 1.05
Undiagnosed coeliac disease and risk of autoimmune disorders in subjects with Type I diabetes mellitus. Diabetologia (2001) 1.01
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer (2008) 1.01
The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol (2003) 1.00
Hypogonadism and pubertal development in Prader-Willi syndrome. Eur J Pediatr (2003) 0.99
Cell cycle alterations and lung cancer. Histol Histopathol (2006) 0.99
Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer. Ann Oncol (2008) 0.99
Tumor regression in mesorectal lymphnodes after neoadjuvant chemoradiation for rectal cancer. Eur J Surg Oncol (2007) 0.98
Transthoracic repair of Morgagni's hernia: a 20-year experience from open to video-assisted approach. Surg Endosc (2006) 0.98
A survey on Prader-Willi syndrome in the Italian population: prevalence of historical and clinical signs. J Pediatr Endocrinol Metab (2009) 0.97
Bisphosphonates: new antiangiogenic molecules in cancer treatment? Ann Oncol (2003) 0.97
Correlation of p53 and bcl-2 expression with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinico-pathological features in colon cancer. Cancer Lett (2004) 0.96
Colorectal carcinomas and PTEN/MMAC1 gene mutations. Clin Cancer Res (2001) 0.96
Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients. Ann Oncol (2010) 0.96
COX-2 expression in DCIS: correlation with VEGF, HER-2/neu, prognostic molecular markers and clinicopathological features. Histopathology (2005) 0.96
New molecular targets in bone metastases. Cancer Treat Rev (2010) 0.95
Transxiphoid bilateral palpation in video-assisted thoracoscopic lung metastasectomy. Arch Surg (2001) 0.95
Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer. Ann Surg Oncol (2001) 0.92
Once daily tacrolimus formulation: monitoring of plasma levels, graft function, and cardiovascular risk factors. Transplant Proc (2010) 0.91
Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD). Ann Oncol (2002) 0.90
Cell cycle related proteins as prognostic parameters in radically resected non-small cell lung cancer. J Clin Pathol (2005) 0.89
Improvement of graft function after conversion to once daily tacrolimus of stable kidney transplant patients. Transplant Proc (2010) 0.89
Thoracoscopic completion thymectomy in refractory nonthymomatous myasthenia. Ann Thorac Surg (2000) 0.89
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients. Ann Oncol (2010) 0.88
Atypical case of metastatic undifferentiated prostate carcinoma in a 36 years old man: clinical report and literature review. Clin Ter (2001) 0.87
Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience. Int J Immunopathol Pharmacol (2012) 0.87
Analysis of cell cycle regulator proteins in non-small cell lung cancer. J Clin Pathol (2004) 0.87
Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab (2013) 0.87
GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology. J Endocrinol Invest (2000) 0.87
Cutting the limits of aminobisphosphonates: new strategies for the potentiation of their anti-tumour effects. Curr Cancer Drug Targets (2009) 0.87
The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE). J Exp Clin Cancer Res (2007) 0.86
Denosumab: the era of targeted therapies in bone metastatic diseases. Curr Cancer Drug Targets (2009) 0.86
Computed tomography for the evaluation of intrathoracic invasion by lung cancer. J Thorac Cardiovasc Surg (1987) 0.86
Local reactions to luteinizing hormone releasing hormone analog therapy. J Pediatr (1995) 0.85
Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma. Thorax (2004) 0.85
Etiology of central precocious puberty in males: the results of the Italian Study Group for Physiopathology of Puberty. J Pediatr Endocrinol Metab (2000) 0.85
Longitudinal evaluation of vitamin D plasma levels during anthracycline- and docetaxel-based adjuvant chemotherapy in early-stage breast cancer patients. Ann Oncol (2009) 0.85
Non-Hodgkin lymphoma among young adults with and without AIDS in Italy. Int J Cancer (2001) 0.85
Transxiphoid video-assisted pulmonary metastasectomy: relevance of helical computed tomography occult lesions. Ann Thorac Surg (2000) 0.84
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival. Thorax (2002) 0.84
Cetuximab in small bowel adenocarcinoma: a new friend? Br J Cancer (2010) 0.84
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer. Pharmacogenomics J (2008) 0.83
RIFLE criteria and hepatic function in the assessment of acute renal failure in liver transplantation. Transplant Proc (2010) 0.83
Mediastinoscopy in superior vena cava obstruction: analysis of 80 consecutive patients. Ann Thorac Surg (1999) 0.83
High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice. Ann Oncol (2010) 0.83
Comparison of clinical-radiological and molecular findings in hypochondroplasia. Am J Med Genet (1998) 0.83
Gemcitabine-induced atrial fibrillation: a hitherto unreported manifestation of drug toxicity. Ann Oncol (2000) 0.83
Human equilibrative nucleoside transporter 1 and carcinoma of the ampulla of Vater: expression differences in tumour histotypes. Eur J Histochem (2010) 0.82
E-cadherin and alpha-catenin expression during tumor progression of cervical carcinoma. Gynecol Oncol (2001) 0.82
Soluble selectin levels in patients with lung cancer. Int J Biol Markers (2002) 0.82
Video-assisted thoracoscopic thymectomy: from the right or from the left? J Thorac Cardiovasc Surg (1997) 0.82
Complementary use of local excision and transanal endoscopic microsurgery for rectal cancer after neoadjuvant chemoradiation. Surg Endosc (2006) 0.82
An omental mass: any hypothesis? Colorectal Dis (2005) 0.82
Tumour proliferation, angiogenesis, and ploidy status in human colon cancer. J Clin Pathol (2005) 0.82
Changes in serum inhibin B during normal male puberty. Eur J Endocrinol (2005) 0.82
A phase I trial of fixed dose rate gemcitabine plus capecitabine in metastatic cancer patients. Ann Oncol (2006) 0.81
Weekly oxaliplatin, 5-fluorouracil and folinic acid (OXALF) as first-line chemotherapy for elderly patients with advanced gastric cancer: results of a phase II trial. BMC Cancer (2006) 0.81
Early childhood caries. Oral health survey in kindergartens of the 19th district in Rome. Minerva Stomatol (2005) 0.81
Smoking habits and sporting activity among adolescents in north Italy. Rev Epidemiol Sante Publique (1991) 0.81
A phase II study of weekly cisplatin, 6S-stereoisomer leucovorin and fluorouracil as first-line chemotherapy for elderly patients with advanced gastric cancer. Br J Cancer (2003) 0.81
Management of puberty in constitutional delay of growth and puberty. J Pediatr Endocrinol Metab (2001) 0.81
Angiogenesis modifications related with cetuximab plus irinotecan as anticancer treatment in advanced colorectal cancer patients. Ann Oncol (2006) 0.81
Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients. Lung Cancer (2004) 0.81
A comparison of lung cancer antigens. Tumori (1976) 0.81
Model for end-stage liver disease score versus simplified acute physiology score criteria in acute renal failure after liver transplantation. Transplant Proc (2011) 0.80
Atypical chronic head and neck pain: don't forget Eagle's syndrome. Eur Rev Med Pharmacol Sci (2008) 0.80
Zoledronic acid for the treatment of appendicular osteosarcoma in a dog. J Small Anim Pract (2008) 0.80
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy. Br J Cancer (2008) 0.80
Impact of lung volume reduction surgery versus rehabilitation on quality of life. Eur Respir J (2004) 0.80